GlobeNews Wire

Axonius Federal Systems Initiates FedRAMP Class D (High) Certification Process

AFS makes commitment to meet the U.S. federal government’s most rigorous security standard May 07, 2026 20:00 ET  | Source:…

9 hours ago

D1SportsNetwork Launches Bilateral Recruiting Portal Connecting Athletes and Coaches Through Comprehensive Digital Profiles

New recruiting platform enables athletes and coaches to search, evaluate, and communicate with centralized sports metrics and academic data. May…

9 hours ago

Trident Announces Hearings Panel Date

May 07, 2026 17:00 ET  | Source: Trident Digital Tech Holdings Ltd SINGAPORE, May 07, 2026 (GLOBE NEWSWIRE) -- Trident…

9 hours ago

MediPharm Labs Sets Date to Report First Quarter 2026 Financial Results

TORONTO, May 07, 2026 (GLOBE NEWSWIRE) -- MediPharm Labs Corp. (TSX: LABS) (OTCQB: MEDIF) (FSE: MLZ) ("MediPharm", "MediPharm Labs" or the "Company")…

12 hours ago

Cue Biopharma Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

May 07, 2026 19:07 ET  | Source: Cue Biopharma, Inc. BOSTON, May 07, 2026 (GLOBE NEWSWIRE) -- Cue Biopharma, Inc.…

12 hours ago

Novi GLP-1 Weight Loss Claims Evaluated: Trusted Semaglutide & Tirzepatide Prescription Medication Treatment Options with Dedicated Doctors

Sheridan, WY, May 07, 2026 (GLOBE NEWSWIRE) -- Compounded medications are not FDA-approved finished drug products. Novi connects eligible adults…

12 hours ago

SteelPower Male Enhancement Ingredient Research Gains Attention Amongst Men for Powerful Performance Support

Aurora, CO, May 06, 2026 (GLOBE NEWSWIRE) -- These statements have not been evaluated by the Food and Drug Administration.…

1 day ago

Cytokinetics Announces Pricing of Upsized Public Offering of Common Stock

SOUTH SAN FRANCISCO, Calif., May 06, 2026 (GLOBE NEWSWIRE) -- Cytokinetics, Incorporated (Nasdaq: CYTK) today announced the pricing of an…

1 day ago

InnoCare Announces Approval of Clinical Trial of Novel CDH7 targeted ADC ICP-B208 in China

BEIJING, May 06, 2026 (GLOBE NEWSWIRE) -- InnoCare Pharma (HKEX: 9969; SSE: 688428), a leading biopharmaceutical company focusing on the…

1 day ago

ImmunityBio Shareholder Alert: ClaimsFiler Reminds Investors With Losses In Excess Of $100,000 Of Lead Plaintiff Deadline In Class Action Lawsuit Against ImmunityBio, Inc. – IBRX

NEW ORLEANS, May 06, 2026 (GLOBE NEWSWIRE) -- ClaimsFiler, a FREE shareholder information service, reminds investors that they have until…

1 day ago